HUB Investment Partners
RXRX icon

HUB Investment Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

HUB Investment Partners’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69K Buy
18,810
+120
+0.6% +$400 ﹤0.01% 1310
2026
Q1 		$57.4K Buy
18,690
+3,169
+20% +$12.2K ﹤0.01% 1098
2025
Q4 		$63.5K Buy
+15,521
New +$76.9K ﹤0.01% 922
2025
Q3 		– Sell
-17,065
Closed -$86.3K – 921
2025
Q2 		$86.3K Buy
+17,065
New +$83.8K ﹤0.01% 687

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HUB Investment Partners's RXRX Position: Q2 2026 in Review

HUB Investment Partners increased its Recursion Pharmaceuticals (RXRX) stake by 0.64% in Q2 2026, buying an estimated $400 and bringing the position to 18,810 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

HUB Investment Partners first reported a position in RXRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $86.3K in Q2 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • HUB Investment Partners held 18,810 shares of Recursion Pharmaceuticals worth $69K as of Q2 2026.
  • HUB Investment Partners bought 120 Recursion Pharmaceuticals shares in Q2 2026, an estimated $400.
  • Recursion Pharmaceuticals made up ﹤0.01% of HUB Investment Partners's portfolio in Q2 2026, its #1310 holding.
  • HUB Investment Partners first reported a position in Recursion Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • HUB Investment Partners's Recursion Pharmaceuticals position peaked at $86.3K in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on HUB Investment Partners's 13F filing for Q2 2026, filed 31 Jul 2026.